| Parenteral pharmaceutical composition used for the treatment of progesterone deficiency disorders, e.g., threatened abortion and pre-eclampsia, comprises fast-acting component comprising dydrogesterone or its salts, long-acting component comprising dydrogesterone or its salts, and excipients | |
| 2023-08-31 | |
| 专利权人 | MANKIND PHARMA LTD (MANK-Non-standard) |
| 申请日期 | 2023-08-31 |
| 专利号 | IN202311058485-A |
| 成果简介 | NOVELTY - Parenteral pharmaceutical composition comprises: a fast-acting component comprising dydrogesterone or its salts; long-acting component comprising dydrogesterone or its salts; and excipients. USE - Parenteral pharmaceutical composition used for the treatment of progesterone deficiency disorders, e.g., threatened abortion and pre-eclampsia. No biological data given. ADVANTAGE - The pharmaceutical composition is optimal, stable, with less to no irritation or pain at the site of injection. |
| IPC 分类号 | A61K-031/565 ; A61K-031/57 ; A61K-009/00 ; A61P-015/00 ; A61P-035/00 ; A61P-009/06 |
| 国家 | 印度 |
| 专业领域 | 医药卫生 |
| 语种 | 英语 |
| 成果类型 | 专利 |
| 文献类型 | 科技成果 |
| 条目标识符 | http://119.78.100.226:8889/handle/3KE4DYBR/20590 |
| 专题 | 中国科学院新疆生态与地理研究所 |
| 作者单位 | MANKIND PHARMA LTD (MANK-Non-standard) |
| 推荐引用方式 GB/T 7714 | KUMAR A,CHUDASAMA V,UPADHYAY S C,et al. Parenteral pharmaceutical composition used for the treatment of progesterone deficiency disorders, e.g., threatened abortion and pre-eclampsia, comprises fast-acting component comprising dydrogesterone or its salts, long-acting component comprising dydrogesterone or its salts, and excipients. IN202311058485-A[P]. 2023. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论